Cantitate/Preț
Produs

Leucine-Rich Repeat Kinase 2 (LRRK2): Advances in Neurobiology, cartea 14

Editat de Hardy J. Rideout
en Limba Engleză Hardback – 4 apr 2017
This is the first book to assemble the leading researchers in the field of LRRK2 biology and neurology and provide a snapshot of the current state of knowledge, encompassing all major aspects of its function and dysfunction. The contributors are experts in cell biology and physiology, neurobiology, and medicinal chemistry, bringing a multidisciplinary perspective on the gene and its role in disease. The book covers the identification of LRRK2 as a major contributor to the pathogenesis of Parkinson's Disease. It also discusses the current state of the field after a decade of research, putative normal physiological roles of LRRK2, and the various pathways that have been identified in the search for the mechanism(s) of its induction of neurodegeneration.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 91727 lei  6-8 săpt.
  Springer International Publishing – 7 aug 2018 91727 lei  6-8 săpt.
Hardback (1) 92308 lei  6-8 săpt.
  Springer International Publishing – 4 apr 2017 92308 lei  6-8 săpt.

Din seria Advances in Neurobiology

Preț: 92308 lei

Preț vechi: 112571 lei
-18% Nou

Puncte Express: 1385

Preț estimativ în valută:
17668 18414$ 14707£

Carte tipărită la comandă

Livrare economică 06-20 ianuarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783319499673
ISBN-10: 331949967X
Pagini: 262
Ilustrații: XVII, 271 p. 27 illus., 17 illus. in color.
Dimensiuni: 155 x 235 x 18 mm
Greutate: 0.59 kg
Ediția:1st ed. 2017
Editura: Springer International Publishing
Colecția Springer
Seria Advances in Neurobiology

Locul publicării:Cham, Switzerland

Cuprins

Part I: Clinical and Genetic Considerations of LRRK2 Associated Parkinson’s Disease.- Leucine-rich repeat kinase (LRRK2) genetics and Parkinson’s disease.- Clinical features of LRRK2 carriers with Parkinson’s disease.- Part II: Fundamentals of LRRK2 Biology.- LRRK2 phosphorylation.- Understanding the GTPase activity of LRRK2: regulation, function and neurotoxicity.- LRRK2 and autophagy.- Molecular insights and functional implication of LRRK2 dimerization.- LRRK2 and the immune system.- Regulation of LRRK2 by phosphatases.- Part III: LRRK2 Neurodegeneration, Modeling, and Therapeutic Options.- Animal models of LRRK2-associated Parkinson’s disease.- LRRK2 and the “LRRKtosome” at the crossroads of programmed cell death: Clues from RIP kinase relatives.- Interaction of LRRK2 and α-synuclein in Parkinson’s disease.- Mechanisms of mutant LRRK2 neurodegeneration.- Small molecule inhibitors of LRRK2.

Textul de pe ultima copertă

This is the first book to assemble the leading researchers in the field of LRRK2 biology and neurology and provide a snapshot of the current state of knowledge, encompassing all major aspects of its function and dysfunction. The contributors are experts in cell biology and physiology, neurobiology, and medicinal chemistry, bringing a multidisciplinary perspective on the gene and its role in disease. The book covers the identification of LRRK2 as a major contributor to the pathogenesis of Parkinson's Disease. It also discusses the current state of the field after a decade of research, putative normal physiological roles of LRRK2, and the various pathways that have been identified in the search for the mechanism(s) of its induction of neurodegeneration.

Caracteristici

Thorough overview of the current state of knowledge on LRRK2 Discussed the links between LRRK2 mutations and Parkinson's Disease Explores what we know about the normal function of LRRK2 Includes supplementary material: sn.pub/extras